Top Industry Leaders in the GERD and NERD Treatment Market
Latest Americas GERD & NERD Treatment Companies Updates:
AstraZeneca: Their proton pump inhibitor (PPI) Nexium continues to be a market leader, but faces patent expiry competition in some regions.
Eisai: Launched Zegerid OTC, an over-the-counter PPI, expanding their market reach.
Ironwood Pharmaceuticals: Their recently approved linaclotide, Linzess, continues to gain traction for chronic constipation and irritable bowel syndrome with constipation (IBS-C), which can overlap with NERD symptoms.
EndoGastric Solutions: Received FDA approval for the Stretta transoral, radiofrequency ablative device for GERD treatment, offering a minimally invasive option.Medtronic: Their RefluxStop device, which uses gastric electrical stimulation for GERD, is undergoing clinical trials and could potentially disrupt the market in the future.
List of Americas GERD & NERD Treatment Key companies in the market:
- AstraZeneca Plc (U.K)
- Boston Scientific Corporation (U.S.)
- Cempra Inc. (U.S.)
- Eisai Co., Ltd. (Japan)
- EndoGastric Solutions Inc. (U.S.)
- EndoStim Inc. (U.S.)
- GlaxoSmithKline Plc (U.K)
- Ironwood Pharmaceuticals, Inc. (U.S.)
- Jeil pharmaceutical Co. Ltd. (South Korea)
- Johnson & Johnson (U.S.)
- Mederi Therapeutics Inc. (U.S.)
- Medigus Ltd. (Israel)
- Medtronic Inc. (U.S.)
- Merck & CO., Inc. (U.S.)
- Novartis AG (Switzerland), Pfizer Inc. (U.S.)
